We are live on
!
Find out more
AP
AlpInvest Partners Portfolio holdings
AUM
$49.7M
1-Year Est. Return
23.93%
This Fund
S&P 500
This Quarter
Est. Return
+15.87%
1 Year Est. Return
+23.93%
3 Year Est. Return
+97.46%
5 Year Est. Return
+64.29%
10 Year Est. Return
+277.58%
AUM
$43.4M
AUM Growth
-$18.2M
(-30%)
Cap. Flow
-$25.7M
Cap. Flow
% of AUM
-59.27%
Top 10 Holdings %
Top 10 Hldgs %
98.08%
Holding
19
New
5
Increased
1
Reduced
7
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
+$994K |
| 2 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
+$975K |
| 3 |
Boise Cascade
BCC
|
+$704K |
| 4 |
ECOM
CHANNELADVISOR CORPORATION
ECOM
|
+$409K |
| 5 |
RALY
RALLY SOFTWARE DEV CORP
RALY
|
+$239K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Globus Medical
GMED
|
+$8.14M |
| 2 |
LPL Financial
LPLA
|
+$5.23M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
+$4.49M |
| 4 |
ServiceNow
NOW
|
+$3.23M |
| 5 |
Pacira BioSciences
PCRX
|
+$1.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 47.28% |
| 2 | Financials | 22.54% |
| 3 | Healthcare | 21.16% |
| 4 | Consumer Discretionary | 3.07% |
| 5 | Consumer Staples | 1.61% |
Similar funds
VCMGDR
SRF
7IH
SAMC
VM
CZI
PEP
OM
AlpInvest Partners's Q1 2014 Portfolio in Review
As of Q1 2014, AlpInvest Partners held 19 positions worth $43.4M, down 30% from $61.6M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
AlpInvest Partners withdrew a net $25.7M in Q1 2014, closing 6 positions and reducing 7 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $4.49M position sold in full.
By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 39% a quarter earlier, followed by Financials and Healthcare.
Against the trend, AlpInvest Partners opened a new position in KYTHERA BIOPHARMACEUTICALS, INC COM worth $884K.
- AlpInvest Partners's largest Q1 2014 buy was KYTHERA BIOPHARMACEUTICALS, INC COM: 22,224 shares worth $884K.
- AlpInvest Partners added most to Coty in Q1 2014, an estimated $183K increase.
- AlpInvest Partners's biggest Q1 2014 reduction was Globus Medical, cutting an estimated $8.14M.
- AlpInvest Partners fully exited Enanta Pharmaceuticals in Q1 2014, selling an estimated $4.49M.
- AlpInvest Partners's ten largest holdings make up 98% of its $43.4M portfolio in Q1 2014.
- AlpInvest Partners opened 5 new positions and closed 6 in Q1 2014.
- AlpInvest Partners's portfolio value fell 30% quarter-over-quarter to $43.4M.
Based on AlpInvest Partners's 13F filing for Q1 2014, filed 15 May 2014.